IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,220,978 | +1135.2% | 215,340 | +1335.6% | 0.01% | +800.0% |
Q2 2021 | $98,850 | -43.2% | 15,000 | -76.6% | 0.00% | 0.0% |
Q1 2019 | $174,000 | -47.4% | 64,100 | +83.1% | 0.00% | -50.0% |
Q3 2018 | $331,000 | -36.8% | 35,000 | -35.1% | 0.00% | -33.3% |
Q2 2018 | $524,000 | +638.0% | 53,900 | +439.0% | 0.00% | – |
Q2 2017 | $71,000 | +610.0% | 10,000 | +1318.4% | 0.00% | – |
Q2 2015 | $10,000 | -99.3% | 705 | -99.5% | 0.00% | -100.0% |
Q1 2015 | $1,397,000 | -7.5% | 156,114 | -37.0% | 0.01% | -11.1% |
Q4 2014 | $1,511,000 | +154.4% | 247,841 | +394.7% | 0.01% | +80.0% |
Q2 2014 | $594,000 | -49.5% | 50,103 | -27.5% | 0.01% | -58.3% |
Q3 2013 | $1,176,000 | – | 69,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |